129 related articles for article (PubMed ID: 7734012)
1. Tissue distribution of the human MDR3 P-glycoprotein.
Smit JJ; Schinkel AH; Mol CA; Majoor D; Mooi WJ; Jongsma AP; Lincke CR; Borst P
Lab Invest; 1994 Nov; 71(5):638-49. PubMed ID: 7734012
[TBL] [Abstract][Full Text] [Related]
2. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
Schinkel AH; Roelofs EM; Borst P
Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-/-) mice.
Smith AJ; de Vree JM; Ottenhoff R; Oude Elferink RP; Schinkel AH; Borst P
Hepatology; 1998 Aug; 28(2):530-6. PubMed ID: 9696021
[TBL] [Abstract][Full Text] [Related]
5. Analysis of random recombination between human MDR1 and mouse mdr1a cDNA in a pHaMDR-dihydrofolate reductase bicistronic expression system.
Shoshani T; Zhang S; Dey S; Pastan I; Gottesman MM
Mol Pharmacol; 1998 Oct; 54(4):623-30. PubMed ID: 9765504
[TBL] [Abstract][Full Text] [Related]
6. Topological folding and proteolysis profile of P-glycoprotein in membranes of multidrug-resistant cells: implications for the drug-transport mechanism.
Zhang M; Wang G; Shapiro A; Zhang JT
Biochemistry; 1996 Jul; 35(30):9728-36. PubMed ID: 8703944
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of P-glycoprotein genes in primary rat hepatocyte culture.
Lee CH; Bradley G; Zhang JT; Ling V
J Cell Physiol; 1993 Nov; 157(2):392-402. PubMed ID: 7901227
[TBL] [Abstract][Full Text] [Related]
8. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT
Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093
[TBL] [Abstract][Full Text] [Related]
9. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.
Cordon-Cardo C; O'Brien JP; Boccia J; Casals D; Bertino JR; Melamed MR
J Histochem Cytochem; 1990 Sep; 38(9):1277-87. PubMed ID: 1974900
[TBL] [Abstract][Full Text] [Related]
10. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.
Schuetz EG; Furuya KN; Schuetz JD
J Pharmacol Exp Ther; 1995 Nov; 275(2):1011-8. PubMed ID: 7473127
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.
Raghu G; Park SW; Roninson IB; Mechetner EB
Exp Hematol; 1996 Aug; 24(10):1258-64. PubMed ID: 8765502
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
[TBL] [Abstract][Full Text] [Related]
13. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
Beck WT; Grogan TM; Willman CL; Cordon-Cardo C; Parham DM; Kuttesch JF; Andreeff M; Bates SE; Berard CW; Boyett JM; Brophy NA; Broxterman HJ; Chan HS; Dalton WS; Dietel M; Fojo AT; Gascoyne RD; Head D; Houghton PJ; Srivastava DK; Lehnert M; Leith CP; Paietta E; Pavelic ZP; Weinstein R
Cancer Res; 1996 Jul; 56(13):3010-20. PubMed ID: 8674056
[TBL] [Abstract][Full Text] [Related]
14. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport.
Hrycyna CA; Airan LE; Germann UA; Ambudkar SV; Pastan I; Gottesman MM
Biochemistry; 1998 Sep; 37(39):13660-73. PubMed ID: 9753453
[TBL] [Abstract][Full Text] [Related]
15. Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response.
Ng IO; Liu CL; Fan ST; Ng M
Am J Clin Pathol; 2000 Mar; 113(3):355-63. PubMed ID: 10705815
[TBL] [Abstract][Full Text] [Related]
16. MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase.
Rao VV; Anthony DC; Piwnica-Worms D
Cancer Res; 1994 Mar; 54(6):1536-41. PubMed ID: 7511043
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of P-glycoprotein in teleost tissues using mammalian polyclonal and monoclonal antibodies.
Hemmer MJ; Courtney LA; Ortego LS
J Exp Zool; 1995 May; 272(1):69-77. PubMed ID: 7738518
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein functions and substrates: possible roles of MDR1 gene in the kidney.
Ernest S; Bello-Reuss E
Kidney Int Suppl; 1998 Apr; 65():S11-7. PubMed ID: 9551426
[TBL] [Abstract][Full Text] [Related]
19. Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.
Fracasso PM; Slapak CA; Nair S; Modrak D; Draper MP; LeCerf JM; Levy SB
Oncol Res; 1997; 9(4):183-91. PubMed ID: 9268989
[TBL] [Abstract][Full Text] [Related]
20. Expression of mdr1/P-glycoprotein and p110 in neuroblastoma.
Ramani P; Dewchand H
J Pathol; 1995 Jan; 175(1):13-22. PubMed ID: 7891222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]